In Vivo Eradication of a Rituximab-Resistant Human CD20+ B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement

被引：0
|
作者：
Betting, David J. [1 ]
Kafi, Kamran [1 ]
Yamada, Reiko E. [1 ]
Steward, Kristopher K. [1 ]
Olafsen, Tove [2 ]
Wu, Anna M. [2 ]
van Rooijen, Nico [3 ]
Timmerman, John M. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA
[3] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, Amsterdam, Netherlands
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [41] Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
    Chu, Yaya
    Hochberg, Jessica
    Yahr, Ashlin
    Ayello, Janet
    van de Ven, Carmella
    Barth, Matthew
    Czuczman, Myron
    Cairo, Mitchell S.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (04) : 333 - 344
  • [42] Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)
    Barth, Matthew
    Hernandez-Ilizaliturri, Francisco J.
    Mavis, Cory
    Tsai, Ping-Chiao
    Gibbs, John
    Deeb, George
    Czuczman, Myron S.
    BLOOD, 2010, 116 (21) : 1598 - 1598
  • [43] Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
    Bil, Jacek
    Winiarska, Magdalena
    Nowis, Dominika
    Bojarczuk, Kamil
    Dabrowska-Iwanicka, Anna
    Basak, Grzegorz W.
    Sulek, Kazimierz
    Jakobisiak, Marek
    Golab, Jakub
    BLOOD, 2010, 115 (18) : 3745 - 3755
  • [44] BORTEZOMIB MODULATES SURFACE CD20 IN B-CELL MALIGNANCIES AND AFFECTS RITUXIMAB-MEDIATED COMPLEMENT-DEPENDENT CYTOTOXICITY
    Winiarska, M.
    Bil, J.
    Bojarczuk, K.
    Nowis, D.
    Golab, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 171 - 172
  • [45] Rituximab maintenenance therapy in CD20+ B-cell Non-Hodgkin-Lymphoma - First interim results of a prospective randomised phase II study.
    Witzens-Harig, M
    Hensel, M
    Neben, K
    Benner, A
    Schmier, JW
    Dreger, P
    Kraemer, A
    Ho, AD
    BLOOD, 2005, 106 (11) : 690A - 690A
  • [46] Lenalidomide strongly enhances natural killer cell and monocyte mediated antibody-dependent cellular cytotoxicity of rituximab treated CD20+VE cancer cells in vitro
    Wu, L.
    Adams, M.
    Schafer, P.
    Muller, G.
    Stirling, D.
    Bartlett, J. B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 113 - 113
  • [47] Oblimersen sodium (G3139) targeting bcl-2 mRNA overcomes acquired resistance to rituximab and sensitizes rituximab-resistant non-Hodgkin's lymphoma (NHL) cells to rituximab-associated complement mediated cytotoxicity (CMC) and antibody dependant cellular cytotoxicity (ADCC).
    Ramanarayanan, J
    Hernandez-Ilizaliturri, FJ
    Czuczman, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 239S - 239S
  • [48] Obinutuzumab (GA101): A novel type II glycoengineered CD20 antibody exhibits enhanced cell death against Rituximab-resistant and -sensitive cell lines in B-cell non-Hodgkin lymphoma
    Tiwari, Aradhana Awasthi
    Ayello, Janet
    Van de Ven, Carmella
    Cairo, Mitchell S.
    CANCER RESEARCH, 2012, 72
  • [49] Epigenetic regulation of CD20 protein expression in B-Cell lymphoma cells after rituximab-containing chemotherapy
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tomoki
    BLOOD, 2007, 110 (11) : 1003A - 1003A
  • [50] Nanoscale distribution of CD20 on B-cell lymphoma tumour cells and its potential role in the clinical efficacy of rituximab
    Li, M.
    Xiao, X.
    Zhang, W.
    Liu, L.
    Xi, N.
    Wang, Y.
    JOURNAL OF MICROSCOPY, 2014, 254 (01) : 19 - 30
12345